Facts and figures

Headquarters

Denmark


International

16 production sites on 5 continents.

Affiliates or offices in 77 countries.

Products marketed in more than 165 countries.


Workforce

Approximately 41,400 employees (June 2017).

19% within research and development
32% in production and production administration
37% in international sales and marketing
12% in administration

Regional distribution:
Africa, Asia, Middle East & Oceania: 6,489
China (4,265) & Taiwan: 4,357
Denmark: 17,804
Europe (excl. HQ): 3,914
Japan (1,105) & Korea: 1,223
Latin America: 1,752
North America (US 5,992 & Canada 302): 6,294
 
(includes all Novo Nordisk and NNE employees in the respective locations)
 

Product areas

We have five product areas:
Diabetes care
Obesity and weight management
Haemophilia management
Growth hormone therapy
Hormone replacement therapy

According to applicable law, only health care professionals are allowed to access product information on our site. Please find the information under Health Care Professionals.

For patient and disease information, including pens and needles, please look under Patients.


Quarterly sale
Q2 2017
 

28,638 million Danish kroner

Annual sale

111,780 million Danish kroner 
(Full year results 2016. See Financial Statement for more information)


Sales by business segment
Q2 2017

Diabetes and obesity care total:
23,770 million Danish kroner

Biopharmaceuticals total:
4,868 million Danish kroner


Sales by region
Q2 2017

North America Operations:
15,103 million Danish kroner

USA: 14,583 million Danish kroner
 

International Operations:
13,535 million Danish kroner

Region Europe: 5,355 million Danish kroner
Region AAMEO: 3,057 million Danish kroner
Region China: 2,608 million Danish kroner
Region Japan & Korea: 1,573 million Danish kroner
Region Latin America: 942 million Danish kroner

 


Novo Nordisk A/S

Bagsværd, Denmark, 
CVR nr. 24 25 67 90

 

 


Financial highlights

Download annual reports, interim reports,
investor presentations and more.

Download centre
 


Share information

Learn more about Novo Nordisk shares.

Shareholder rights
 


Novo Nordisk products

Facts about Novo Nordisk products

Product facts